Article Information
History
- July 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Noriko Satoh-Asahara, MD PhDa,b,*,
- Hajime Yamakage, MEnga,
- Masashi Tanaka, PhDa,c,
- Teruaki Kawasaki, MD, PhDd,
- Sayo Matsuurae,
- Harutsugu Tatebe, PhDe,
- Ichiro Akiguchi, MD, PhDd and
- Takahiko Tokuda, MD, PhDe
- aClinical Research Institute for Endocrine & Metabolic Disease, National Hospital Organization, Kyoto Medical Center, 1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto 612-8555, Japan
- bDepartment of Metabolic Syndrome and Nutritional Science, Research Institute of Environmental Medicine, Nagoya University, Aichi 464-8601, Japan
- cDepartment of Physical Therapy, Health Science University, Yamanashi 401-0380, Japan
- dCenter of Neurological and Cerebrovascular Diseases, Koseikai Takeda Hospital, Kyoto, Japan
- eDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba, 263-0024, Japan
- ↵*Corresponding authors: Noriko Satoh-Asahara, M.D., Ph.D., Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, 1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto, Japan, Phone: +81-75-641-9161, Fax: +81-75-645-2781; E-mail: nsatoh{at}kuhp.kyoto-u.ac.jp
Posted July 07, 2022.
Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of diabetic patients based on their cognitive status
